Weiping Tang

This inventor holds 16 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Wisconsin Alumni Research Foundation, Harvard College, Dana-Farber-Cancer Institute Inc.. Active years: 2012-2026.

USPTO Granted Patents = 16 (Patent Applications = 12)

% Patents Active = 87.5

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 66(Granted Patents)

Location History:

Madison, WI (US) (2013 - 2015)
Middleton, WI (US) (2012 - 2022)

Company Filing History:

10 out of 4,226

Wisconsin Alumni Research Foundation

Dana-Farber-Cancer Institute Inc.

patents

4. 1 out of 8,568

Massachusetts Institute of Technology

patents

5. 1 out of 3,067

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527741 - MODULAR DENDRON MICELLES FOR TREATMENT OF PULMONARY DISEASES RELATED TO FIBROSIS AND VIRAL INFECTION INCLUDING COVID-19 (2026-01-20),

2. 12514850 - Synthesis of small molecule histone deacetylase 6 degraders, compounds formed thereby, and pharmaceutical compositions containing them (2026-01-06),

3. 12390447 - Sirtuin 6 protein deacylase (SIRT6) activators (2025-08-19),

4. 11427569 - Benzoimidazole indolyl methanes and methods of using them to inhibit PCKS9 and PCKS9-mediated ailments (2022-08-30),

5. 11059815 - Synthesis of small molecule histone deacetylase 6 degraders, compounds formed thereby, and pharmaceutical compositions containing them (2021-07-13),

6. 11045458 - Synthesis of small molecule histone deacetylase 6 degraders, compounds formed thereby, and pharmaceutical compositions containing them (2021-06-29),

7. 10730833 - Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them (2020-08-04),

8. 10508092 - Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them (2019-12-17),

9. 10174008 - Synthesis of cyclopropyl indoles and cyclohepta[B]indoles, pharmaceutical compositions containing them and method of using them (2019-01-08),

10. 9969686 - Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them (2018-05-15),

11. 9434686 - Deacetylase inhibitors and uses thereof (2016-09-06),

12. 8927280 - Compositions and methods for promoting the generation of definitive endoderm (2015-01-06),

13. 8754237 - Bifunctional histone deacetylase inhibitors (2014-06-17),

14. 8507274 - Compositions and methods for promoting the generation of definitive endoderm (2013-08-13),

15. 8440716 - Deacetylase inhibitors and uses thereof (2013-05-14),

Title: Weiping Tang: Innovator in Pulmonary Disease Treatment

Introduction

Weiping Tang is a prominent inventor based in Middleton, WI (US), known for his significant contributions to the field of medicine, particularly in the treatment of pulmonary diseases. With a total of 16 patents to his name, Tang has made remarkable strides in developing innovative therapeutic solutions.

Latest Patents

Among his latest patents are groundbreaking inventions such as "Modular Dendron Micelles for Treatment of Pulmonary Diseases Related to Fibrosis and Viral Infection Including COVID-19." He has also developed a synthesis of small molecule histone deacetylase 6 degraders, along with compounds formed thereby and pharmaceutical compositions containing them. Another notable patent involves histone deacetylase ('HDAC')-selective inhibitors that are covalently bonded to a linker, which is in turn bonded to an E3 ubiquitin ligase ligand, along with salts thereof and methods of using the composition to inhibit neoplastic cell growth in mammals, including humans.

Career Highlights

Weiping Tang has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and Harvard College. His work in these institutions has allowed him to push the boundaries of research and innovation in his field.

Collaborations

Throughout his career, Tang has collaborated with notable individuals, including Stuart L. Schreiber and Ka Yang, who have contributed to his research endeavors.

Conclusion

Weiping Tang's innovative work in the treatment of pulmonary diseases showcases his dedication to advancing medical science. His numerous patents reflect his commitment to finding effective solutions for complex health issues.